News

Genentech is developing GDC-0449 under a collaboration agreement with Curis and will be the sponsor of this study. GDC-0449 will be evaluated in approximately 100 patients with ovarian

Takeda has been conducting Phase I clinical studies of Hematide for the treatment of chemotherapy-induced anemia in the US and Japan. However, the companies have decided to suspend

Health Management Associates (HMA) expects to use the proceeds of the sale for general corporate purposes, which includes debt repayment. HMA owns and operates 56 hospitals, with approximately

As a part of the 510(k), Instrumentation Laboratory (IL) performed a multi-center clinical study involving more than 600 patients in four different hospitals, according to a strict protocol

Under the terms of the agreement, Valeant will grant GlaxoSmithKline (GSK) worldwide development and commercialization rights to retigabine, VRX698 and the other back-up compounds from the potassium channel

According to Mr Ahmadinejad, Iran has made great strides in the pharmaceuticals field and is ready to compete in the global pharmaceutical market. The president called upon the

Terms of the transaction were not disclosed, though Summer Street is said to use its aggregate $300 million under management to make equity investments that typically range from

Mr Beier is a veteran of the biotechnology industry and has been instrumental in the development of US public policy impacting biotechnology companies, having served in both the

The research programs in Israel are the CB2 receptor selective library of compounds, including preclinical development of PRS-639,058 for neuropathic pain. Additionally, the company has almost completed a